Jeroen Verhoeven

Jeroen Verhoeven

Department of Diagnostic Sciences, Ghent University

Affiliated withGhent University

Research Area

Cancer Research

Biography

Jeroen Verhoeven has not added Biography.
If you are Jeroen Verhoeven and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 1	Year
Publication title	2022

Other Publications

Article	Year
Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice. PloS one\| PubMed ID: 28273180	2017
Evaluating Hepatobiliary Transport with F-Labeled Bile Acids: The Effect of Radiolabel Position and Bile Acid Structure on Radiosynthesis and and Performance. Contrast media & molecular imaging\| PubMed ID: 29853807	2018
Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[F]FCA in mouse models of liver disease. Nuclear medicine and biology\| PubMed ID: 30595544	2019
The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review. Frontiers in medicine\| PubMed ID: 30761302	2019
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma. Scientific reports\| PubMed ID: 30814660	2019
Technical feasibility of [F]FET and [F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model. Radiation oncology (London, England)\| PubMed ID: 31146757	2019
PET quantification of [18F]MPPF in the canine brain using blood input and reference tissue modelling. PloS one\| PubMed ID: 31185062	2019
Cost-Effectiveness of [F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma. Frontiers in oncology\| PubMed ID: 31555584	2019
Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A preclinical F98 glioblastoma rat model study. PloS one\| PubMed ID: 31634381	2019
Kinetic analysis of [F] altanserin bolus injection in the canine brain using PET imaging. BMC veterinary research\| PubMed ID: 31752848	2019
2-[F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. Nuclear medicine and biology\| PubMed ID: 31841816	2020
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [F]fluorophenylglutamine and [F]fluorobiphenylglutamine. Nuclear medicine and biology\| PubMed ID: 32447069	2020
Radiosynthesis, in vitro and preliminary biological evaluation of [ F]2-amino-4-((2-((3-fluorobenzyl)oxy)benzyl)(2-((3-(fluoromethyl)benzyl)oxy)benzyl)amino)butanoic acid, a novel alanine se... Journal of labelled compounds & radiopharmaceuticals\| PubMed ID: 32472945	2020
Development of a Rat Model for Glioma-Related Epilepsy. International journal of molecular sciences\| PubMed ID: 32977526	2020
Intra-individual dynamic comparison of F-PSMA-11 and Ga-PSMA-11 in LNCaP xenograft bearing mice. Scientific reports\| PubMed ID: 33273603	2020
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma. Theranostics\| PubMed ID: 34335972	2021
Comparison of In Vivo and Ex Vivo Magnetic Resonance Imaging in a Rat Model for Glioblastoma-Associated Epilepsy. Diagnostics (Basel, Switzerland)\| PubMed ID: 34441246	2021
Impact of the molar activity and PSMA expression level on [F]AlF-PSMA-11 uptake in prostate cancer. Scientific reports\| PubMed ID: 34799653	2021
Recent advancements in F-labeled PSMA targeting PET radiopharmaceuticals. Nuclear medicine and biology\| PubMed ID: 34998217	2022